H. Lundbeck A/S (HLBBF)
6.64
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.588B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 24.27% |
| Valuation | |
| PE Ratio | 10.86 |
| PE Ratio (Forward) | |
| PS Ratio | 1.644 |
| Price to Book Value | 1.603 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.1832 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.3505 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark. |
| URL | http://www.lundbeck.com |
| Investor Relations URL | N/A |
| HQ State/Province | Capital Region |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 11, 2026 (est.) |
| Last Earnings Release | Aug. 19, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 20, 2026 |
Profile
| H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark. |
| URL | http://www.lundbeck.com |
| Investor Relations URL | N/A |
| HQ State/Province | Capital Region |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 11, 2026 (est.) |
| Last Earnings Release | Aug. 19, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 20, 2026 |